← Back to contracts

DoW Tuberous Sclerosis Complex, Exploration-Hypothesis Development Award

US · MD Dept › of the Army -- USAMRAA (U › S › Army Medical Research Acquisition Activity) grant open #HT942526TSCRPEHDA
Response due Aug 06, 2026 · 00:00 UTC

Summary

The U.S. Army Medical Research Acquisition Activity (USAMRAA), under the Department of Defense, is soliciting applications for an Exploration-Hypothesis Development Award focused on Tuberous Sclerosis Complex (TSC). This is a research grant opportunity aimed at supporting early-stage, hypothesis-driven scientific investigation into TSC, a rare genetic disorder. The award is part of the Congressionally Directed Medical Research Programs (CDMRP) DoW (Department of Defense) grant mechanism. Full programmatic details, eligibility criteria, and funding specifics are not provided in the synopsis but are expected in the full funding opportunity announcement.

What they want

Applicants are invited to submit proposals for an Exploration-Hypothesis Development Award under the Tuberous Sclerosis Complex Research Program (TSCRP). The award mechanism is designed to support novel, exploratory research focused on generating or testing a specific hypothesis related to Tuberous Sclerosis Complex. This is a federal grant (not a procurement contract) administered through USAMRAA on behalf of the Department of the Army. Full scope, allowable costs, and research priorities are to be detailed in the complete program announcement.

Risks & flags

  • Extremely limited detail in synopsis — full scope, award ceiling, eligibility, and evaluation criteria are not disclosed, making competitive assessment impossible at this stage.

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Tuberous Sclerosis Complex, Exploratio…
Due Aug 06
Onboard